General Information
BounceWatch is an independent company data service, not affiliated with AveXis. To contact AveXis, visit avexis.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does AveXis compare?
A PDF of AveXis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting AveXis soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is AveXis on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About AveXis
Business keywords: Gene Therapy, Neurological Genetic Diseases, Rare Diseases, Medical Innovation, Novartis, Acquisition, Life-Threatening Conditions, Research & Development, Therapeutic Innovations
Funding Rounds & Investors (5)
View AllAveXis Alternatives & Competitors
View All AlternativesPioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Antitrypsin De...
Dedicated to addressing the root cause of rare genetic diseases and promising hope for patients in n...
Biotech company develops treatments for severe rare diseases, aims to become global leader with pati...
FAQ About AveXis
Source: BounceWatch company record for AveXis, https://bouncewatch.com/company/avexis, updated 27 December 2024. When citing, please name BounceWatch and link this page.